BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250606T000000
DTEND;TZID=America/New_York:20260606T000000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Recorded Webinar Featuring Harry Karmouty-Quintana\, Ph.D.
DESCRIPTION:Dr. Harry Karmouty-Quintana\, Associate Professor in the Department of Biochemistry and Molecular Biology at McGovern Medical School\, UT Health Houston\, will present his talk entitled\, "Sugar-coated scars: Hyaluronan remodeling of the lung matrix in pulmonary hypertension."Abstract: Pulmonary hypertension (PH)\, a progressive vascular disease that is commonly present in chronic lung conditions such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). A hallmark of PH is vascular remodeling\, yet the role of extracellular matrix dynamics in this process is not fully defined. Hyaluronan (HA)\, a matrix glycan elevated in IPF\, COPD\, and PH\, is a key contributor to this remodeling. We identify pulmonary artery smooth muscle cells (PASMCs) as a central source of HA overproduction in PH\, driven by 3'UTR shortening of HAS2 following loss of NUDT21\, a regulator of alternative polyadenylation. This dysregulation leads to mitochondrial dysfunction and a in PASMCs\, promoting proliferation\, migration\, and increased contractility. Mice overexpressing HAS2 in smooth muscle develop spontaneous PH\, while genetic deletion or pharmacologic inhibition of HAS2 restores mitochondrial function and reverses disease features. These findings reveal a shared HA-driven mechanism linking chronic lung disease to PH pathogenesis.
X-ALT-DESC;FMTTYPE=text/html:Dr. Harry Karmouty-Quintana\, Associate Professor in the Department of Biochemistry and Molecular Biology at McGovern Medical School\, UT Health Houston\, will present his talk entitled\, "\;Sugar-coated scars: Hyaluronan remodeling of the lung matrix in pulmonary hypertension."\;
Abstract: Pulmonary hypertension (PH)\, a progressive vascular disease that is commonly present in chronic lung conditions such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). A hallmark of PH is vascular remodeling\, yet the role of extracellular matrix dynamics in this process is not fully defined. Hyaluronan (HA)\, a matrix glycan elevated in IPF\, COPD\, and PH\, is a key contributor to this remodeling. We identify pulmonary artery smooth muscle cells (PASMCs) as a central source of HA overproduction in PH\, driven by 3'\;UTR shortening of HAS2 following loss of NUDT21\, a regulator of alternative polyadenylation. This dysregulation leads to mitochondrial dysfunction and a in PASMCs\, promoting proliferation\, migration\, and increased contractility. Mice overexpressing HAS2 in smooth muscle develop spontaneous PH\, while genetic deletion or pharmacologic inhibition of HAS2 restores mitochondrial function and reverses disease features. These findings reveal a shared HA-driven mechanism linking chronic lung disease to PH pathogenesis.
LOCATION:
UID:e.2142.1212582
SEQUENCE:3
DTSTAMP:20260430T085239Z
URL:https://members.navbo.org/calendar-of-events/Details/recorded-webinar-featuring-harry-karmouty-quintana-ph-d-1415901?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR